Trials that use: Interim analysis / alpha spending
New to this method? Read the tutorial →
11,819 results
- MUSICIndependent statistical analysis of Evaluate the Safety and Tolerability, for Nirsevimab in Immunocompromised Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04484935).
- Music During Labor Epidural Placement and Patient Satisfaction: Complete Statistical AnalysisIndependent statistical analysis of Music During Labor Epidural Placement and Patient Satisfaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02734056).
- Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma: Complete Statistical AnalysisIndependent statistical analysis of Music Therapy Advocacy Recording Intervention (MTAR) on Internalized Stigma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05723328).
- Music Therapy in Sickle Cell Pain Mixed Methods Study: Complete Statistical AnalysisIndependent statistical analysis of Music Therapy in Sickle Cell Pain Mixed Methods Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02270060).
- Music Therapy Versus Control for Total Knee Arthroplasty: Complete Statistical AnalysisIndependent statistical analysis of Music Therapy Versus Control for Total Knee Arthroplasty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03569397).
- Music vs. No Music During Cesarean Delivery on Patient Satisfaction: Complete Statistical AnalysisIndependent statistical analysis of Music vs. No Music During Cesarean Delivery on Patient Satisfaction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03412019).
- MUSICAIndependent statistical analysis of A Study to Determine the Effect of Methotrexate (MTX) Dose on Clinical Outcome and Ultrasonographic Signs in Subjects With Moderately to Severely Active Rheumatoid Arthritis (RA) Treated With…
- MUSTCOOLIndependent statistical analysis of Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MUTEXIndependent statistical analysis of Cetuximab in Refractory Colorectal Cancer With K-RAS Mutated and Favorable FcγRIIa (CD32) Genotype: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MVOR-2Independent statistical analysis of A Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea (MVOR-2): primary endpoint results, effect estimate with confidence interval, sample-size…
- MVPIndependent statistical analysis of Bortezomib With Melphalan and Prednisone for Multiple Myeloma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00734149).
- My Dose Coach Mobile App to Support Insulin Titration and Maintenance: Complete Statistical AnalysisIndependent statistical analysis of My Dose Coach Mobile App to Support Insulin Titration and Maintenance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health: Complete Statistical AnalysisIndependent statistical analysis of Myalgic Encephalomyelitis Chronic Fatigue at the National Institutes of Health: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02669212).
- MYDAYISIndependent statistical analysis of Study of the Duration and Efficacy of MYDAYIS on Adult ADHD Symptoms and Executive Function Throughout the Day Into the Early Evening: primary endpoint results, effect estimate with…
- myDExIndependent statistical analysis of Development of a Tailored HIV Prevention Intervention for Young Men: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02842060).
- Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Conditioning Orca-T & Allogeneic Donor-Derived CD19/CD22-CAR TCells in B-Cell ALL: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases: Complete Statistical AnalysisIndependent statistical analysis of Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00309842).
- Myoc GeneIndependent statistical analysis of Effect of Myocilin Genetic Variants on Intraocular Pressure and Pressure Variation in Sitting and Supine Positions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Myocardial Injury and Quality of Life After COVID-19: Complete Statistical AnalysisIndependent statistical analysis of Myocardial Injury and Quality of Life After COVID-19: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04794062).
- myOpportunITy2Independent statistical analysis of A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- myOpportunITy3Independent statistical analysis of A Study to Investigate the Long-term Safety, Tolerability, and Efficacy of Rozanolixizumab in Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP): primary endpoint results, effect estimate…
- MYPAICEIndependent statistical analysis of Mindfulness and Yoga for Pain With Interstitial Cystitis Evaluation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04820855).
- MYSTICIndependent statistical analysis of Phase III Open Label First Line Therapy Study of MEDI 4736 (Durvalumab) With or Without Tremelimumab Versus SOC in Non Small-Cell Lung Cancer (NSCLC): primary endpoint results, effect…
- MYTechIndependent statistical analysis of Me & You-Tech: A Socio-Ecological Solution to Teen Dating Violence for the Digital Age: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- N-3 PUFA and Rheumatoid Arthritis in Korea: Complete Statistical AnalysisIndependent statistical analysis of N-3 PUFA and Rheumatoid Arthritis in Korea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01618019).
- N-Acetyl Cysteine in Pathologic Skin Picking: Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl Cysteine in Pathologic Skin Picking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01063348).
- N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): Complete Statistical AnalysisIndependent statistical analysis of N-Acetyl-L-Leucine for GM2 Gangliosidosis (Tay-Sachs and Sandhoff Disease): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03759665).
- N-Acetylcysteine for Patients With COPD and Chronic Bronchitis: Complete Statistical AnalysisIndependent statistical analysis of N-Acetylcysteine for Patients With COPD and Chronic Bronchitis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01739790).
- N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine in Non-Acetaminophen Pediatric Acute Liver Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00248625).
- N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults: Complete Statistical AnalysisIndependent statistical analysis of N-acetylcysteine to Reduce Oxidative Stress and Improve Endothelial Function in HIV-infected Older Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- N-ForceIndependent statistical analysis of N-Force Screws Augmented With N-Force Blue in Hip Fractures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03807349).
- N08HMEIndependent statistical analysis of Short-term Clinical Feasibility of the Provox XtraHMEs for Pulmonary Rehabilitation After Total Laryngectomy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- N30-005Independent statistical analysis of Pharmacokinetic Evaluation of Brisdelle™ (Formerly Known as Mesafem) Following Single & Repeat Oral Administration in Healthy Postmenopausal Women: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- N6 Input Processing in Traditional CI Recipients: Complete Statistical AnalysisIndependent statistical analysis of N6 Input Processing in Traditional CI Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02239263).
- Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: Complete Statistical AnalysisIndependent statistical analysis of Nab-Pac+Cis+Gem in Pts w Previously Untreated Metastatic PDA: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01893801).
- Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel and Bevacizumab Followed By Bevacizumab and Erlotinib in Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel and Bevacizumab or Ipilimumab as First-Line Therapy in Treating Patients With Stage IV Melanoma That Cannot Be Removed by Surgery: primary endpoint results, effect estimate with confidence…
- Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: Complete Statistical AnalysisIndependent statistical analysis of Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery: primary endpoint results, effect estimate with…
- Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel in Treating Older Patients With Locally Advanced or Metastatic Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: Complete Statistical AnalysisIndependent statistical analysis of Nab-Paclitaxel, Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Nabilone in Cannabis Users With PTSD: Complete Statistical AnalysisIndependent statistical analysis of Nabilone in Cannabis Users With PTSD: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03251326).
- NABIS:HIIRIndependent statistical analysis of Effects of Hypothermia Upon Outcomes After Acute Traumatic Brain Injury: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00178711).
- NACIndependent statistical analysis of Effectiveness of N-Acetylcysteine (NAC) in Treating Cocaine Dependent Individuals - 1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NACIndependent statistical analysis of N-acetylcysteine Treatment of Alcohol Use Disorder In Veterans With TBI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02791945).
- NAC cold coughIndependent statistical analysis of Study to Evaluate the Efficacy of N-acetylcysteine (NAC) in the Treatment of the Common Cold and Cough: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- NAD+ Precursor Supplementation in Friedreich’s Ataxia: Complete Statistical AnalysisIndependent statistical analysis of NAD+ Precursor Supplementation in Friedreich's Ataxia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04817111).
- NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis: Complete Statistical AnalysisIndependent statistical analysis of NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis: primary endpoint results, effect estimate…
- NAFLDIndependent statistical analysis of Endoscopic Ultrasound(EUS)-Guided TRUCUT Biopsy (EUS-TCB) of Suspected Nonalcoholic Fatty Liver Disease(NAFLD.): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- NAFT-600Independent statistical analysis of Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…